Gonen B, Rochman H, Rubenstein A H
Metabolism. 1979 Apr;28(4 Suppl 1):448-52. doi: 10.1016/0026-0495(79)90054-4.
Hemoglobin A1 concentrations were measured in 230 patients with diabetes mellitus. Diabetic patients controlled by diet alone had significantly lower HbA1 levels compared to the insulin or oral hypoglycemic treated groups. Only 13% of insulin-treated patients had HbA1 levels below 10%, while 26% of the oral agent treated group and 70% of the diet treated group fell into this range. The HbA1 levels correlated with fasting and nonfasting plasma glucose concentrations. However, in certain patients, discrepant results between these two variables were found. Hemoglobin A1 was measured on three or more occasions in 60 patients over a 1-yr period. An improvement was noted in 40%, no change in 38%, and a deterioration in 22%. Hemoglobin A1 measurements have proved to be useful in the follow-up and treatment of diabetic patients.
对230例糖尿病患者测定了糖化血红蛋白A1浓度。与胰岛素治疗组或口服降糖药治疗组相比,单纯饮食控制的糖尿病患者糖化血红蛋白A1水平显著更低。胰岛素治疗组中只有13%的患者糖化血红蛋白A1水平低于10%,而口服降糖药治疗组为26%,饮食治疗组为70%。糖化血红蛋白A1水平与空腹及非空腹血糖浓度相关。然而,在某些患者中,发现这两个变量之间存在不一致的结果。在1年时间内对60例患者进行了3次或更多次糖化血红蛋白A1测定。结果显示,40%的患者病情有所改善,38%的患者无变化,22%的患者病情恶化。糖化血红蛋白A1测定已被证明在糖尿病患者的随访和治疗中有用。